Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...

In EAGLE-3, gepotidacin was statistically significantly superior to nitrofurantoin, with 58.5% of patients having therapeutic success (combined clinical and microbiological response) vs 43.6% of ...

RICHLAND, Wash. — Two men responsible for trafficking large amounts of drugs across eastern Washington have been sentenced in federal prison. In December 2022, investigators executed several ...

Some claim that patients with mental health conditions such as depression can access the drug 'within 72 hours'. Some experts have even claimed that the widespread rollout of medical cannabis ...

Nuclear medicine technologists inject small amounts of radioactive material into patients and then take images of their patients' bodies to diagnose or determine the progression of certain ...